Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.4818
-0.0088
(-1.79%)
As of 4:00:45 PM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-50,940
-70,453
-94,779
-59,832
-23,750
Investing Cash Flow
-16,623
43,952
-20,415
-49,097
-1,220
Financing Cash Flow
56,360
15,243
17,462
125,804
138,314
End Cash Position
22,035
34,755
46,013
143,745
126,870
Capital Expenditure
-406
-1,871
-9,601
-5,157
-1,223
Issuance of Capital Stock
56,289
15,030
17,237
122,210
111,109
Free Cash Flow
-51,346
-72,324
-104,380
-64,989
-24,973
12/31/2020 - 3/8/2002
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1FG.F FibroGen, Inc.
0.3715
-0.21%
NVV1.DU Novavax Inc
7.96
+16.74%
RGO.SG Regeneron Pharmaceuticals Inc
670.20
-0.21%
0RQE.IL Idorsia Ltd
1.1960
-12.25%
CDTTW Conduit Pharmaceuticals Inc.
0.0125
-0.79%
TYRA Tyra Biosciences, Inc.
11.51
-1.71%
NVCT Nuvectis Pharma, Inc.
6.40
-4.33%
ERAS Erasca, Inc.
1.3050
-4.74%
GUTS Fractyl Health, Inc.
1.5000
-3.85%
SKYE Skye Bioscience, Inc.
2.8400
-0.35%